Dapagliflozin for the treatment of heart failure with reduced ejection fraction in Brazil: a cost-effectiveness analysisResearch in context by Marcio Coutinho Xavier Naves, Angelica Amorim Amato, Ivan Ricardo Zimmermann, Henry Maia Peixoto

Subjects: Get full text

Repurposing dapagliflozin for Alzheimer's disease: a mechanistic exploration by Marwa M. Saeed

Subjects: “…Dapagliflozin…”
Get full text

Combination of dapagliflozin and pioglitazone lacks superiority against monotherapy in streptozotocin-induced nephropathy by Aneta Cinakova, Diana Vavrincova-Yaghi, Peter Krenek, Jan Klimas, Eva Kralova

Subjects: Get full text

Animal experiments and network pharmacology to explore the anti-inflammatory mechanism of dapagliflozin in the treatment of polycystic ovary syndrome by Yong Liu, He Bai, Huilin Guan, Chunhua Wang, Xueqing Song, Zihao Yong, Xiaomeng Guo, Luxin Li, Zhen Zhang

Subjects: “…Dapagliflozin…”
Get full text

Repurposing Dapagliflozin for Mitigation of the Kidney Injury Triggered by Cadmium in Rats: Role of Autophagy, Apoptosis, and the SIRT1/Nrf2/HO-1 Pathway by Hany H. Arab, Musaad M. Althobaiti, Abdulaziz S. Alharthi, Emad O. Almalki, Saif S. Alsoubie, Jawad M. Qattan, Saeed A. Almalki, Ahmed M. Ashour, Ahmed H. Eid

Subjects: Get full text

Effects of Empagliflozin and Dapagliflozin in alleviating cardiac fibrosis through SIRT6-mediated oxidative stress reduction by Hong-xia Ma, Ke Wu, Fei-hong Dong, Bing-kun Cai, Di Wu, Hui-yi Lu

Subjects: Get full text

Dapagliflozin and Sirtuin-1 interaction and mechanism for ameliorating atrial fibrillation in a streptozotocin-induced rodent diabetic model by Wei-Chieh Lee, Yu-Wen Lin, Jhih-Yuan Shih, Zhih-Cherng Chen, Nan-Chun Wu, Wei-Ting Chang, Ping-Yen Liu

Subjects: Get full text

Efficacy and prognosis of dapagliflozin in the treatment of patients with acute myocardial infarction complicated with type 2 diabetes in Xining area by Jinping Chai, Delian Li, Yanmin Liu, Xiaoling Su

Subjects: Get full text

Losartan and dapagliflozin combination therapy in reducing uric acid level compared to monotherapy in patients with heart failure by Tuong Le Trong Huynh, Phong Thanh Pham, Hien Dieu Tran, Nhan Dinh Tran, Duong Van Tran, Bao Lam Thai Tran, Khoa Dang Dang Tran, Toan Hoang Ngo, Son Kim Tran

Subjects: Get full text

Comparison of the efficacy of dapagliflozin and linagliptin in the treatment of type 2 diabetes patients with normal body mass index and poor metformin monotherapy by Mingli He, Li Jiang, Su Zhang, Xinrong Yang

Subjects: “…Dapagliflozin…”
Get full text

Economic evaluation of adding dapagliflozin to standard care in the treatment of chronic kidney disease: a systematic review by Lu Wang, Yinglin Wang, Quan Zhao

Subjects: Get full text

Blue applicability grade index assessment and response surface modelling to synchronous determination of metformin hydrochloride, vildagliptin and dapagliflozin propanediol monohyd... by Pintu Prajapati, Krutika Patil, Dhrumi Naik, Veera Shakar Pulusu, Anzarul Haque, Mohd Abul Kalam, Shailesh Shah

Subjects: Get full text

Dapagliflozin improves diabetic kidney disease by inhibiting ferroptosis through β-hydroxybutyrate production by Yan Tian, Chenxia Zhou, Qun Yan, Ziyi Li, Da Chen, Bo Feng, Jun Song

Subjects: Get full text

SGLT-2 inhibitors in the management of acute decompensated heart failure by Anastasia E. Poskakalova, Svetlana N. Nasonova, Igor V. Zhirov, Sergey N. Tereshchenko

Subjects: Get full text

Dapagliflozin in acute heart failure management: a systematic review and meta-analysis of safety and effectiveness by Adarsh Raja, Mata-e-Alla Dogar, Sandesh Raja, Muhammad Hamza Shuja, Shafin Bin Amin, Muskan Khelani, Urooj Fatima, Aiman Soomro, Ayesha Habiba, Iqra Mustafa, Rakhshan Zulfiqar, Muhammad Sohaib Asghar

Subjects: “…Dapagliflozin…”
Get full text

Sodium glucose co-transporter 2 inhibitors (SGLT2i) for pediatric kidney disease: the future is near by Gilda M. Portalatin, Irene Hong-McAtee, Irene Hong-McAtee, Anna M. Burgner, Edward R. Gould, Tracy E. Hunley, Tracy E. Hunley

Subjects: Get full text

The effects of Dapagliflozin in a real-world population of HFrEF patients with different hemodynamic profiles: worse is better by Francesco Loria, Pasquale Mone, Antonella Rispoli, Rosanna Di Fonzo, Daniele Masarone, Costantino Mancusi, Michele Correale, Antonio Vitullo, Michele Granatiero, Pietro Mazzeo, Valentina Mercurio, Francesco Fiore, Elena Di Sarro, Luigi Falco, Carmine Izzo, Alfonso Campanile, Nicola Virtuoso, Eugenio Stabile, Salvatore Bonanno, Giuseppe Dattilo, Carlo Gabriele Tocchetti, Gaetano Santulli, Carmine Vecchione, Michele Ciccarelli, Valeria Visco

Subjects: “…Dapagliflozin…”
Get full text

Euglycemic diabetic ketoacidosis associated metabolic encephalopathy caused by dapagliflozin: a rare case report by Lulu Chu, Zhenhua Xi, Runzhi Ma, Weiliang Shi, Guoshen Yu

Subjects: “…Dapagliflozin…”
Get full text

Possible Beneficial Effect of Dapagliflozin in Improvement of Dyspnea Scale (VAS and SA-NYHA Class) in Patients with Acute Decompensated Heart Failure (ADHF) by Hanna Jassim Dohei, Maitham Ali Al-Rikabi

Subjects: “…Dapagliflozin, Acute Decompensated Heart Failure, Dyspnea Scale, Visual Analog Scale, 5-point Likert scale…”
Get full text

SGLT2 inhibitors for alleviating heart failure through non-hypoglycemic mechanisms by Ya-ru Chen, Fang-yuan Zhu, Rong Zhou

Subjects: Get full text